A detailed history of Norden Group LLC transactions in Insulet Corp stock. As of the latest transaction made, Norden Group LLC holds 5,601 shares of PODD stock, worth $1.48 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,601
Previous 3,478 61.04%
Holding current value
$1.48 Million
Previous $702 Million 85.74%
% of portfolio
0.15%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$180.69 - $239.01 $383,604 - $507,418
2,123 Added 61.04%
5,601 $1.3 Billion
Q2 2024

Aug 06, 2024

BUY
$161.02 - $206.98 $122,375 - $157,304
760 Added 27.96%
3,478 $702 Million
Q1 2024

Apr 30, 2024

SELL
$163.6 - $209.11 $3.57 Million - $4.57 Million
-21,843 Reduced 88.93%
2,718 $466 Million
Q1 2024

Apr 19, 2024

BUY
$163.6 - $209.11 $3.73 Million - $4.76 Million
22,777 Added 1276.74%
24,561 $4.21 Billion
Q4 2023

Feb 05, 2024

BUY
$127.77 - $221.42 $227,941 - $395,013
1,784 New
1,784 $387 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.